Literature DB >> 35427438

Forward Genetic Screens of Human Glycosylation Pathways Using the GlycoGene CRISPR Library.

Anju Kelkar1, Theodore Groth1, Sriram Neelamegham1.   

Abstract

CRISPR-Cas9-based forward genetic screens represent a powerful discovery platform to uncover genes regulating specific biological processes. This article describes a method for utilizing a freely available GlycoGene CRISPR library to knock out any gene participating in human glycosylation in arbitrary cell types. The end product is a stable GlycoGene CRISPR knockout cell library, where each cell contains one or more sgRNA and lacks corresponding function. The cell library can be screened using various lectin/antibody reagents. It can also be applied in functional assays to establish glycan structure-glycogene-glycopathway relationships. This is a powerful systems glycobiology strategy for dissecting glycosylation pathways and processes.
© 2022 Wiley Periodicals LLC. Basic Protocol 1: Scale-up and NGS validation of the GlycoGene CRISPR plasmid library Basic Protocol 2: Preparation of a GlycoGene CRISPR lentivirus pool and an isogenic cell line stably expressing Cas9 nuclease Basic Protocol 3: Preparation of a GlycoGene CRISPR cell library, self-inactivation of Cas9, and library validation by NGS Basic Protocol 4: Enrichment of lectin-binding or non-binding cells and related multiplex NGS data acquisition Basic Protocol 5: Bioinformatics pathway analysis. © 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  CRISPR-Cas9; glycogene; glycosylation; lectin; pathway analysis

Mesh:

Substances:

Year:  2022        PMID: 35427438      PMCID: PMC9467456          DOI: 10.1002/cpz1.402

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  25 in total

1.  Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines.

Authors:  Catharina Steentoft; Sergey Y Vakhrushev; Malene B Vester-Christensen; Katrine T-B G Schjoldager; Yun Kong; Eric Paul Bennett; Ulla Mandel; Hans Wandall; Steven B Levery; Henrik Clausen
Journal:  Nat Methods       Date:  2011-10-09       Impact factor: 28.547

2.  ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes.

Authors:  Nandini Mondal; Alexander Buffone; Gino Stolfa; Aristotelis Antonopoulos; Joseph T Y Lau; Stuart M Haslam; Anne Dell; Sriram Neelamegham
Journal:  Blood       Date:  2014-12-10       Impact factor: 22.113

3.  Using CRISPR-Cas9 to quantify the contributions of O-glycans, N-glycans and Glycosphingolipids to human leukocyte-endothelium adhesion.

Authors:  Gino Stolfa; Nandini Mondal; Yuqi Zhu; Xinheng Yu; Alexander Buffone; Sriram Neelamegham
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

Review 4.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

Authors:  Thomas Gaj; Charles A Gersbach; Carlos F Barbas
Journal:  Trends Biotechnol       Date:  2013-05-09       Impact factor: 19.536

5.  Systems-level studies of glycosyltransferase gene expression and enzyme activity that are associated with the selectin binding function of human leukocytes.

Authors:  Dhananjay D Marathe; E V Chandrasekaran; Joseph T Y Lau; Khushi L Matta; Sriram Neelamegham
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

6.  Silencing α1,3-fucosyltransferases in human leukocytes reveals a role for FUT9 enzyme during E-selectin-mediated cell adhesion.

Authors:  Alexander Buffone; Nandini Mondal; Rohitesh Gupta; Kyle P McHugh; Joseph T Y Lau; Sriram Neelamegham
Journal:  J Biol Chem       Date:  2012-11-28       Impact factor: 5.157

7.  Efficient inhibition of O-glycan biosynthesis using the hexosamine analog Ac5GalNTGc.

Authors:  Shuen-Shiuan Wang; Virginia Del Solar; Xinheng Yu; Aristotelis Antonopoulos; Alan E Friedman; Kavita Agarwal; Monika Garg; Syed Meheboob Ahmed; Ahana Addhya; Mehrab Nasirikenari; Joseph T Lau; Anne Dell; Stuart M Haslam; Srinivasa-Gopalan Sampathkumar; Sriram Neelamegham
Journal:  Cell Chem Biol       Date:  2021-02-19       Impact factor: 8.116

8.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

Authors:  John G Doench; Nicolo Fusi; Meagan Sullender; Mudra Hegde; Emma W Vaimberg; Jennifer Listgarten; Katherine F Donovan; Ian Smith; Zuzana Tothova; Craig Wilen; Robert Orchard; Herbert W Virgin; David E Root
Journal:  Nat Biotechnol       Date:  2016-01-18       Impact factor: 54.908

9.  A GlycoGene CRISPR-Cas9 lentiviral library to study lectin binding and human glycan biosynthesis pathways.

Authors:  Yuqi Zhu; Theodore Groth; Anju Kelkar; Yusen Zhou; Sriram Neelamegham
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

Review 10.  Genetic glycoengineering in mammalian cells.

Authors:  Yoshiki Narimatsu; Christian Büll; Yen-Hsi Chen; Hans H Wandall; Zhang Yang; Henrik Clausen
Journal:  J Biol Chem       Date:  2021-02-20       Impact factor: 5.157

View more
  1 in total

1.  Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity.

Authors:  Qi Yang; Anju Kelkar; Anirudh Sriram; Ryoma Hombu; Thomas A Hughes; Sriram Neelamegham
Journal:  Sci Adv       Date:  2022-09-23       Impact factor: 14.957

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.